These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 2702312

  • 21. Hepatic manifestations of inflammatory bowel diseases.
    Restellini S, Chazouillères O, Frossard JL.
    Liver Int; 2017 Apr; 37(4):475-489. PubMed ID: 27712010
    [Abstract] [Full Text] [Related]

  • 22. Hepatobiliary disease in inflammatory bowel disease.
    Balan V, LaRusso NF.
    Gastroenterol Clin North Am; 1995 Sep; 24(3):647-69. PubMed ID: 8809241
    [Abstract] [Full Text] [Related]

  • 23. Primary sclerosing cholangitis.
    Geonzon-Gonzales MR.
    Gastroenterol Nurs; 2007 Sep; 30(2):102-5; quiz 105-7. PubMed ID: 17440311
    [Abstract] [Full Text] [Related]

  • 24. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R, Angelucci E, Cocco A, Viscido A, Annese V, Ardizzone S, Biancone L, Castiglione F, Cottone M, Meucci G, Paoluzi P, Papi C, Sturniolo GC, Vecchi M.
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [Abstract] [Full Text] [Related]

  • 25. [Inflammatory bowel disease and colorectal cancer].
    Hagymási K, Tulassay Z.
    Orv Hetil; 2006 Oct 15; 147(41):1977-82. PubMed ID: 17120688
    [Abstract] [Full Text] [Related]

  • 26. Phenotypic and functional characteristics of colonic lymphocytes isolated from patients with primary sclerosing cholangitis and inflammatory bowel disease.
    Silvain C, Zeevi A, Saidman S, Duquesnoy RJ, Van Thiel DH.
    Hepatogastroenterology; 1995 Jul 15; 42(3):250-8. PubMed ID: 7590574
    [Abstract] [Full Text] [Related]

  • 27. [Primary sclerosing cholangitis].
    Rösch T, Dancygier H.
    Leber Magen Darm; 1988 Aug 15; 18(4):184-96. PubMed ID: 3063908
    [Abstract] [Full Text] [Related]

  • 28. Hypereosinophilia, ulcerative colitis, sclerosing cholangitis, and bile duct carcinoma.
    Mir-Madjlessi SH, Sivak MV, Farmer RG.
    Am J Gastroenterol; 1986 Jun 15; 81(6):483-5. PubMed ID: 3706270
    [Abstract] [Full Text] [Related]

  • 29. Extraintestinal manifestations of idiopathic inflammatory bowel disease.
    Danzi JT.
    Arch Intern Med; 1988 Feb 15; 148(2):297-302. PubMed ID: 3277559
    [Abstract] [Full Text] [Related]

  • 30. Does primary sclerosing cholangitis occurring in association with inflammatory bowel disease differ from that occurring in the absence of inflammatory bowel disease? A study of sixty-six subjects.
    Rabinovitz M, Gavaler JS, Schade RR, Dindzans VJ, Chien MC, Van Thiel DH.
    Hepatology; 1990 Jan 15; 11(1):7-11. PubMed ID: 2295474
    [Abstract] [Full Text] [Related]

  • 31. Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: an immunomodulating antibiotic.
    Davies YK, Cox KM, Abdullah BA, Safta A, Terry AB, Cox KL.
    J Pediatr Gastroenterol Nutr; 2008 Jul 15; 47(1):61-7. PubMed ID: 18607270
    [Abstract] [Full Text] [Related]

  • 32. Chronic pancreatitis and inflammatory bowel disease: true or coincidental association?
    Barthet M, Hastier P, Bernard JP, Bordes G, Frederick J, Allio S, Mambrini P, Saint-Paul MC, Delmont JP, Salducci J, Grimaud JC, Sahel J.
    Am J Gastroenterol; 1999 Aug 15; 94(8):2141-8. PubMed ID: 10445541
    [Abstract] [Full Text] [Related]

  • 33. Predictors of pouchitis after ileal pouch-anal anastomosis: a retrospective review.
    Hoda KM, Collins JF, Knigge KL, Deveney KE.
    Dis Colon Rectum; 2008 May 15; 51(5):554-60. PubMed ID: 18266037
    [Abstract] [Full Text] [Related]

  • 34. Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of disease.
    Wiesner RH.
    Best Pract Res Clin Gastroenterol; 2001 Aug 15; 15(4):667-80. PubMed ID: 11492975
    [Abstract] [Full Text] [Related]

  • 35. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer.
    Broomé U, Bergquist A.
    Semin Liver Dis; 2006 Feb 15; 26(1):31-41. PubMed ID: 16496231
    [Abstract] [Full Text] [Related]

  • 36. [Importance of liver puncture biopsy and endoscopic retrograde cholangiography in patients with chronic anicteric unexplained cholestasis. A retrospective study in 79 patients].
    Sapey T, Turlin B, Canva-Delcambre V, Mendler MH, Deugnier Y, Brissot P, Guyader D.
    Gastroenterol Clin Biol; 1999 Feb 15; 23(2):178-85. PubMed ID: 10353011
    [Abstract] [Full Text] [Related]

  • 37. [Clinical course of inflammatory bowel disease in patients transplanted for primary sclerosing cholangitis].
    Villamil A, De Paula JA, Galdame O, Piccioni H, Ciardullo M, De Santibañes E, Gadano A.
    Acta Gastroenterol Latinoam; 2008 Dec 15; 38(4):252-9. PubMed ID: 19157380
    [Abstract] [Full Text] [Related]

  • 38. Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.
    Rojas-Feria M, Castro M, Suárez E, Ampuero J, Romero-Gómez M.
    World J Gastroenterol; 2013 Nov 14; 19(42):7327-40. PubMed ID: 24259964
    [Abstract] [Full Text] [Related]

  • 39. Hepatobiliary complications of inflammatory bowel disease.
    Williams SM, Harned RK.
    Radiol Clin North Am; 1987 Jan 14; 25(1):175-88. PubMed ID: 3547468
    [Abstract] [Full Text] [Related]

  • 40. Liver and inflammatory bowel disease.
    Nahon S, Cadranel JF, Chazouilleres O, Biour M, Jouannaud V, Marteau P.
    Gastroenterol Clin Biol; 2009 May 14; 33(5):370-81. PubMed ID: 19394180
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.